The Trajan (ASX:TRJ) share price is up 38% in under two weeks

This recent IPO has been on fire since listing…

| More on:
asx share price surge represented by hand holding rocket taking off

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Trajan Group Holdings (ASX: TRJ) share price has been a strong performer since its IPO earlier this month.

Since hitting the ASX boards on 7 June, the shares of the global developer and manufacturer of analytical science instruments, devices and solutions are up an impressive 38% from their listing price.

Based on the current Trajan share price, the company now has a market capitalisation of just over $300 million.

What is Trajan?

Trajan was established in 2011 and is a global participant in the analytical science instrument and device industry.

According to its prospectus, it is a purpose led business that aims to enrich human wellbeing through the design, manufacture and supply of products and solutions that enhance scientific measurement.

Trajan's precision componentry and solutions are used in the analysis of biological, food, and environmental samples across a variety of segments that impact human wellbeing. They also have a broad range of life science applications including pharmaceutical, clinical diagnostics, and pathology.

In addition to this, the company has developed a portfolio of innovative technologies and devices which are expected to support the trend towards decentralised, personalised data‑based healthcare.

Why is the Trajan share price shooting higher?

One of the reasons investors have been bidding the Trajan share price higher might be its sizeable and growing market opportunity.

One segment of the global analytical science industry in which Trajan operates is the mass spectrometry market, which was valued at US$4.1 billion in 2020.

End‑user segments within this market include pharmaceutical applications which are projected to grow at a CAGR of 9.3% and environmental testing which is projected to have a CAGR of 6.5% from 2020 to 2025.

For now, it is forecasting revenue of $74.65 million and EBITDA of $9.5 million in FY 2021 and then revenue of $82.5 million and EBITDA of $10.7 million in FY 2022.

Trajan IPO

Trajan raised gross proceeds of $90 million at an offer price of $1.70 per share from its IPO.

Management notes that the proceeds raised will predominantly be used to execute the company's growth strategy. This strategy encompasses both strategic acquisitions of complementary businesses, technologies and processes, and continued investment in its proprietary technology and device portfolio.

Some of the proceeds were also used to give existing shareholders the opportunity to realise a minority part of their investment in the company.

Given its bright prospects and high quality technology, it might be worth keeping an eye on the Trajan share price in 2021.

James Mickleboro does not own any shares mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Why Capricorn Metals, Insignia, Perseus Mining, and Qoria shares are storming higher

These shares are having a strong session on Tuesday. But why?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

A businessman stacks building blocks.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX shares hit a new record high today.

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why Auckland Airport, Australian Ethical, Breville, and Clarity shares are charging higher

These shares are having a better day than most on Thursday. But why?

Read more »

A man sits on a bench atop a mountain with a laptop, making investments with a green ESG mind.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors endured a day to forget this hump day.

Read more »